Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_assertion evidence source_evidence_literature NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_assertion SIO_000772 22334453 NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_assertion wasDerivedFrom befree-2016 NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_assertion wasGeneratedBy ECO_0000203 NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.
- befree-2016 importedOn "2016-02-19" NP960927.RAG7u8IwPZS9PTQTSd9WUAsh9E0FRWlVck5Khl-EiDBG0130_provenance.